Charles River Laboratories International, Inc. (CRL) Q1 2012 Earnings Results

Charles River Laboratories Beats on EPS, Stock Down 0.17%

Charles River Laboratories reported a better-than-expected EPS of $0.70, which was a positive surprise for investors. However, the stock reacted slightly negatively, declining by 0.17%. The lack of revenue figures and guidance may have contributed to the stock's muted response, as investors typically look for comprehensive insights into future performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.70	N/A	+7.36%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding the company's performance. They highlighted the importance of continued focus on operational improvements.

Management expressed satisfaction with the EPS performance despite not providing revenue figures.

They emphasized ongoing efforts to enhance operational efficiency.

Charles River Laboratories Beats on EPS, Stock Down 0.17%

Key numbers

Management commentary

Charles River Laboratories International, Inc.

More earnings this week

Charles River Laboratories Beats on EPS, Stock Down 0.17%

Key numbers

Management commentary